Lilly’s Oncology Bet: A 62% Response Rate Builds the Bull Case—Phase 3 Must Deliver


‼️ 💊 Lilly’s Next Oncology Trade: A 62% Response Rate Opens the Door. Phase 3 Will Decide the Economics.

Read More: https://bit.ly/LLY-LungCancer

#EliLilly #LLY #BiotechInvesting #Oncology #EquityResearch #InstitutionalInvesting #DrugPricing

Leave a Reply